Table 1 Baseline characteristics of participants grouped according to different serum chloride.
Serum chloride | P | |||||
|---|---|---|---|---|---|---|
Total (n = 2596) | Q1 (n = 639) | Q2 (n = 625) | Q3 (n = 673) | Q4 (n = 659) | ||
Age, years | 72.00 (64.00–80.00) | 72.00 (63.00–80.00) | 71.00 (63.00–80.00) | 72.00 (64.00–79.00) | 73.00 (66.00–81.50) | 0.013 |
Gender, n (%) | 0.189 | |||||
Male | 1360 (52.39) | 313 (48.98) | 343 (54.88) | 359 (53.34) | 345 (52.35) | |
Female | 1236 (47.61) | 326 (51.02) | 282 (45.12) | 314 (46.66) | 314 (47.65) | |
Weight, kg | 78.38 (65.00–95.11) | 80.00 (64.00–100.00) | 80.00 (65.00–96.90) | 78.60 (65.60–94.50) | 75.80 (63.40–89.80) | 0.001 |
WBC, K/µL | 11.50 (8.40–15.28) | 10.80 (7.97–14.48) | 11.40 (8.10–15.23) | 11.51 (8.47–15.60) | 12.08 (9.25–15.77) | < 0.001 |
RBC, K/µL | 3.49 (3.04–4.01) | 3.62 (3.06–4.11) | 3.57 (3.07–4.09) | 3.52 (3.10–4.01) | 3.35 (2.97–3.74) | < 0.001 |
Platelet, K/µL | 189.50 (140.46–253.00) | 203.50 (148.12–282.00) | 198.50 (148.00–261.67) | 188.50 (143.75–240.00) | 167.67 (129.79–224.17) | < 0.001 |
Hemoglobin, g/dL | 10.38 (8.90–11.80) | 10.40 (8.91–12.09) | 10.60 (9.00–12.10) | 10.55 (9.13–11.90) | 10.00 (8.80–11.27) | < 0.001 |
RDW, % | 14.75 (13.70–16.30) | 15.00 (13.91–16.90) | 14.80 (13.77–16.35) | 14.48 (13.50–16.05) | 14.75 (13.60–16.02) | < 0.001 |
Sodium, mmol/L | 139.00 (136.00–141.33) | 135.00 (131.67–138.33) | 138.00 (135.67–140.00) | 139.33 (137.33–141.50) | 141.00 (139.00–143.50) | < 0.001 |
Potassium, mmol/L | 4.28 (3.95–4.68) | 4.30 (3.99–4.80) | 4.30 (3.97–4.68) | 4.27 (3.92–4.61) | 4.23 (3.93–4.60) | 0.011 |
Calcium, mmol/L | 8.40 (8.00–8.80) | 8.65 (8.19–9.02) | 8.47 (8.00–8.80) | 8.40 (8.00–8.80) | 8.14 (7.80–8.50) | < 0.001 |
Glucose, mmol/L | 130.00 (110.00–163.04) | 140.00 (113.00–178.75) | 134.00 (111.25–168.50) | 127.50 (109.00–156.00) | 125.00 (107.00–151.00) | < 0.001 |
PT, sec | 13.90 (12.40–16.40) | 14.00 (12.40–17.66) | 13.88 (12.30–16.15) | 13.75 (12.27–15.95) | 13.98 (12.66–16.14) | 0.016 |
PTT, sec | 32.60 (28.10–43.16) | 34.07 (28.48–47.81) | 33.60 (28.45–43.83) | 32.00 (27.80–42.05) | 31.13 (27.98–38.93) | < 0.001 |
BUN, mg/dL | 21.00 (14.73–34.00) | 24.50 (16.41–42.05) | 20.50 (14.00–31.00) | 19.50 (14.00–30.33) | 21.00 (14.12–35.67) | < 0.001 |
sCR, mg/dL | 1.00 (0.70–1.47) | 1.05 (0.70–1.86) | 1.00 (0.70–1.40) | 0.93 (0.70–1.32) | 1.00 (0.77–1.50) | < 0.001 |
SOFA | 4.00 (2.00–7.00) | 4.00 (2.00–7.00) | 4.00 (2.00–7.00) | 4.00 (2.00–7.00) | 5.00 (3.00–8.00) | < 0.001 |
APS III | 42.00 (32.00–55.00) | 46.00 (34.00–58.00) | 42.00 (33.00–53.00) | 40.00 (31.00–51.00) | 42.00 (32.00–56.00) | < 0.001 |
SIRS | 3.00 (2.00–3.00) | 3.00 (2.00–3.00) | 3.00 (2.00–3.00) | 3.00 (2.00–3.00) | 3.00 (2.00–3.00) | 0.061 |
SAPS II | 37.00 (30.00–45.00) | 37.00 (29.00–45.00) | 36.00 (29.00–44.00) | 36.00 (29.00–44.00) | 39.00 (32.00–47.50) | < 0.001 |
SBP, mmHg | 114.55 (106.14–126.13) | 116.57 (106.19–127.94) | 115.56 (106.50–127.23) | 114.86 (106.48–125.99) | 112.04 (104.95–123.31) | 0.004 |
DBP, mmHg | 63.28 (57.32–70.00) | 63.83 (57.56–70.61) | 65.00 (59.27–71.79) | 63.08 (57.75–70.08) | 61.30 (55.55–68.00) | < 0.001 |
Hypertension, n (%) | 1042 (40.14) | 230 (35.99) | 261 (41.76) | 292 (43.39) | 259 (39.30) | 0.038 |
Diabetes, n (%) | 860 (33.13) | 230 (35.99) | 215 (34.40) | 224 (33.28) | 191 (28.98) | 0.047 |
Heart failure, n (%) | 1134 (43.68) | 356 (55.71) | 268 (42.88) | 271 (40.27) | 239 (36.27) | < 0.001 |
Myocardial infarction, n (%) | 334 (12.87) | 87 (13.62) | 74 (11.84) | 90 (13.37) | 83 (12.59) | 0.776 |
CKD, n (%) | 617 (23.77) | 165 (25.82) | 133 (21.28) | 138 (20.51) | 181 (27.47) | 0.006 |
Stroke, n (%) | 233 (8.98) | 57 (8.92) | 54 (8.64) | 61 (9.06) | 61 (9.26) | 0.984 |
Hyperlipidemia, n (%) | 1192 (45.92) | 266 (41.63) | 266 (42.56) | 333 (49.48) | 327 (49.62) | 0.002 |
90-day mortality, n (%) | 657 (25.31) | 211 (33.02) | 142 (22.72) | 142 (21.10) | 162 (24.58) | < 0.001 |
365-day mortality, n (%) | 941 (36.25) | 306 (47.89) | 202 (32.32) | 214 (31.80) | 219 (33.23) | < 0.001 |
